163 related articles for article (PubMed ID: 18603026)
1. Effect of acetazolamide on ventilatory response in subjects with chronic mountain sickness.
Rivera-Ch M; Huicho L; Bouchet P; Richalet JP; León-Velarde F
Respir Physiol Neurobiol; 2008 Aug; 162(3):184-9. PubMed ID: 18603026
[TBL] [Abstract][Full Text] [Related]
2. Selected contribution: Ventilatory response to CO2 in high-altitude natives and patients with chronic mountain sickness.
Fatemian M; Gamboa A; Léon-Velarde F; Rivera-Ch M; Palacios JA; Robbins PA
J Appl Physiol (1985); 2003 Mar; 94(3):1279-87; discussion 1253-4. PubMed ID: 12571150
[TBL] [Abstract][Full Text] [Related]
3. The effects of acetazolamide on the ventilatory response to high altitude hypoxia.
Burki NK; Khan SA; Hameed MA
Chest; 1992 Mar; 101(3):736-41. PubMed ID: 1541140
[TBL] [Abstract][Full Text] [Related]
4. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E
Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide reduces exercise capacity and increases leg fatigue under hypoxic conditions.
Garske LA; Brown MG; Morrison SC
J Appl Physiol (1985); 2003 Mar; 94(3):991-6. PubMed ID: 12391068
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide: a treatment for chronic mountain sickness.
Richalet JP; Rivera M; Bouchet P; Chirinos E; Onnen I; Petitjean O; Bienvenu A; Lasne F; Moutereau S; León-Velarde F
Am J Respir Crit Care Med; 2005 Dec; 172(11):1427-33. PubMed ID: 16126936
[TBL] [Abstract][Full Text] [Related]
7. Acetazolamide for Monge's disease: efficiency and tolerance of 6-month treatment.
Richalet JP; Rivera-Ch M; Maignan M; Privat C; Pham I; Macarlupu JL; Petitjean O; León-Velarde F
Am J Respir Crit Care Med; 2008 Jun; 177(12):1370-6. PubMed ID: 18388356
[TBL] [Abstract][Full Text] [Related]
8. Respiratory control in residents at high altitude: physiology and pathophysiology.
León-Velarde F; Richalet JP
High Alt Med Biol; 2006; 7(2):125-37. PubMed ID: 16764526
[TBL] [Abstract][Full Text] [Related]
9. Peripheral chemoreceptor function after carbonic anhydrase inhibition during moderate-intensity exercise.
Scheuermann BW; Kowalchuk JM; Paterson DH; Cunningham DA
J Appl Physiol (1985); 1999 May; 86(5):1544-51. PubMed ID: 10233116
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of prophylactic use of acetazolamide in subjects with acute mountain sickness.
Hung PH; Lin FC; Tsai HC; Chao HS; Chou CW; Chang SC
J Chin Med Assoc; 2019 Feb; 82(2):126-132. PubMed ID: 30839503
[TBL] [Abstract][Full Text] [Related]
11. Autonomic cardiovascular function in high-altitude Andean natives with chronic mountain sickness.
Keyl C; Schneider A; Gamboa A; Spicuzza L; Casiraghi N; Mori A; Ramirez RT; Leon-Velarde F; Bernardi L
J Appl Physiol (1985); 2003 Jan; 94(1):213-9. PubMed ID: 12391057
[TBL] [Abstract][Full Text] [Related]
12. Selected contribution: Peripheral chemoreflex function in high-altitude natives and patients with chronic mountain sickness.
Léon-Velarde F; Gamboa A; Rivera-Ch M; Palacios JA; Robbins PA
J Appl Physiol (1985); 2003 Mar; 94(3):1269-78; discussion 1253-4. PubMed ID: 12571149
[TBL] [Abstract][Full Text] [Related]
13. Using modified Fenn diagrams to assess ventilatory acclimatization during ascent to high altitude: Effect of acetazolamide.
Isakovich R; Cates VC; Pentz BA; Bird JD; Vanden Berg ER; de Freitas EM; Nysten CE; Leacy JK; O'Halloran KD; Brutsaert TD; Sherpa MT; Day TA
Exp Physiol; 2024 Jul; 109(7):1080-1098. PubMed ID: 38747161
[TBL] [Abstract][Full Text] [Related]
14. The effect of acetazolamide on hypercapnic and eucapnic/poikilocapnic hypoxic ventilatory responses in normal subjects.
Bashir Y; Kann M; Stradling JR
Pulm Pharmacol; 1990; 3(3):151-4. PubMed ID: 2135218
[TBL] [Abstract][Full Text] [Related]
15. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange.
Grissom CK; Roach RC; Sarnquist FH; Hackett PH
Ann Intern Med; 1992 Mar; 116(6):461-5. PubMed ID: 1739236
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the ventilatory response in subjects susceptible to high altitude pulmonary edema during acute and prolonged hypoxia.
Schirlo C; Pavlicek V; Jacomet A; Gibbs JS; Koller E; Oelz O; Seebauer M; Kohl J
High Alt Med Biol; 2002; 3(3):267-76. PubMed ID: 12396880
[TBL] [Abstract][Full Text] [Related]
17. Effect of acetazolamide on pulmonary and muscle gas exchange during normoxic and hypoxic exercise.
Jonk AM; van den Berg IP; Olfert IM; Wray DW; Arai T; Hopkins SR; Wagner PD
J Physiol; 2007 Mar; 579(Pt 3):909-21. PubMed ID: 17218362
[TBL] [Abstract][Full Text] [Related]
18. Acetazolamide in control of acute mountain sickness.
Lancet; 1981 Jan; 1(8213):180-3. PubMed ID: 6109857
[TBL] [Abstract][Full Text] [Related]
19. Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness.
Wright AD; Beazley MF; Bradwell AR; Chesner IM; Clayton RN; Forster PJ; Hillenbrand P; Imray CH;
Wilderness Environ Med; 2004; 15(1):25-31. PubMed ID: 15040503
[TBL] [Abstract][Full Text] [Related]
20. Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation.
Larson EB; Roach RC; Schoene RB; Hornbein TF
JAMA; 1982 Jul; 248(3):328-32. PubMed ID: 7045433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
